Degludec outperforms glargine in reducing nocturnal hypoglycemia

05/21/2013 | InternalMedicineNews.com (free registration)

Type 1 diabetes patients who took high doses of insulin degludec once daily had lower rates of nocturnal hypoglycemia during the full trial and maintenance periods than those who took insulin glargine, a meta-analysis indicated. The findings were presented at the American Association of Clinical Endocrinologists annual meeting.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC